Blood test could spot rare nerve tumors years earlier in NF1 patients

This study is testing whether a blood test (liquid biopsy) can detect a rare but serious nerve tumor called MPNST earlier than current methods in adults with Neurofibromatosis Type 1 (NF1). Researchers will compare the timing of tumor detection by the blood test versus standard imaging and exams. The goal is to see if this approach leads to earlier treatment and better outcomes, especially for people who face barriers to healthcare.